Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment

J Sharifi-Rad, C Quispe, M Butnariu, LS Rotariu… - Cancer cell …, 2021 - Springer
The study describes the current state of knowledge on nanotechnology and its utilization in
medicine. The focus in this manuscript was on the properties, usage safety, and potentially …

Polysaccharide-based nanomedicines targeting lung cancer

AA Bhat, G Gupta, KS Alharbi, O Afzal, ASA Altamimi… - Pharmaceutics, 2022 - mdpi.com
A primary illness that accounts for a significant portion of fatalities worldwide is cancer.
Among the main malignancies, lung cancer is recognised as the most chronic kind of cancer …

Amelioration of cancer employing chitosan, its derivatives, and chitosan-based nanoparticles: recent updates

T Virmani, G Kumar, A Sharma, K Pathak, MS Akhtar… - Polymers, 2023 - mdpi.com
The limitations associated with the conventional treatment of cancer have necessitated the
design and development of novel drug delivery systems based mainly on nanotechnology …

A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers

RM Rasul, MT Muniandy, Z Zakaria, K Shah… - Carbohydrate …, 2020 - Elsevier
Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial
and anti-cancer properties. It lately has received a widespread interest for use as the …

[HTML][HTML] Recent advances and prospects of hyaluronan as a multifunctional therapeutic system

NG Kotla, SR Bonam, S Rasala, J Wankar… - Journal of Controlled …, 2021 - Elsevier
Hyaluronan (HA) is a naturally occurring non-sulfated glycosaminoglycan (GAG), cell-
surface-associated biopolymer and is the key component of tissue extracellular matrix …

Chitosan nanoparticle-based system: A new insight into the promising controlled release system for lung cancer treatment

C Yee Kuen, MJ Masarudin - Molecules, 2022 - mdpi.com
Lung cancer has been recognized as one of the most often diagnosed and perhaps most
lethal cancer diseases worldwide. Conventional chemotherapy for lung cancer-related …

RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer

AS Yadav, NNV Radharani, M Gorain, A Bulbule… - Nanoscale, 2020 - pubs.rsc.org
Acidic pH is a crucial intrinsic property of the microenvironment of most solid tumors. Hence,
the use of pH sensitive tumor targeting nanoparticles is an attractive approach to enhance …

Chitosan–hyaluronic acid nanoparticles for active targeting in cancer therapy

LE Puluhulawa, IM Joni, KM Elamin, AFA Mohammed… - Polymers, 2022 - mdpi.com
Cancer is the most common cause of death worldwide; therefore, there is a need to discover
novel treatment modalities to combat it. One of the cancer treatments is nanoparticle …

[HTML][HTML] Nanocarriers for anticancer drugs: Challenges and perspectives

AI Alqosaibi - Saudi Journal of Biological Sciences, 2022 - Elsevier
Cancer is the second most common cause of death globally, surpassed only by
cardiovascular disease. One of the hallmarks of cancer is uncontrolled cell division and …

Connecting the dots in drug delivery: a tour d'horizon of chitosan-based nanocarriers system

S Pramanik, V Sali - International Journal of Biological Macromolecules, 2021 - Elsevier
One of the most promising pharmaceutical research areas is developing advanced delivery
systems for controlled and sustained drug release. The drug delivery system (DDS) can be …